Anti-LRRK2 monoclonal antibody

Pre-made anti-LRRK2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LRRK2/LRRK2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T08123-Ab-1/ GM-Tg-hg-T08123-Ab-2Anti-Human LRRK2 monoclonal antibodyHuman
GM-Tg-rg-T08123-Ab-1/ GM-Tg-rg-T08123-Ab-2Anti-Rat LRRK2 monoclonal antibodyRat
GM-Tg-mg-T08123-Ab-1/ GM-Tg-mg-T08123-Ab-2Anti-Mouse LRRK2 monoclonal antibodyMouse
GM-Tg-cynog-T08123-Ab-1/ GM-Tg-cynog-T08123-Ab-2Anti-Cynomolgus/ Rhesus macaque LRRK2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T08123-Ab-1/ GM-Tg-felg-T08123-Ab-2Anti-Feline LRRK2 monoclonal antibodyFeline
GM-Tg-cang-T08123-Ab-1/ GM-Tg-cang-T08123-Ab-2Anti-Canine LRRK2 monoclonal antibodyCanine
GM-Tg-bovg-T08123-Ab-1/ GM-Tg-bovg-T08123-Ab-2Anti-Bovine LRRK2 monoclonal antibodyBovine
GM-Tg-equg-T08123-Ab-1/ GM-Tg-equg-T08123-Ab-2Anti-Equine LRRK2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T08123-Ab-1/ GM-Tg-hg-T08123-Ab-2; GM-Tg-rg-T08123-Ab-1/ GM-Tg-rg-T08123-Ab-2;
GM-Tg-mg-T08123-Ab-1/ GM-Tg-mg-T08123-Ab-2; GM-Tg-cynog-T08123-Ab-1/ GM-Tg-cynog-T08123-Ab-2;
GM-Tg-felg-T08123-Ab-1/ GM-Tg-felg-T08123-Ab-2; GM-Tg-cang-T08123-Ab-1/ GM-Tg-cang-T08123-Ab-2;
GM-Tg-bovg-T08123-Ab-1/ GM-Tg-bovg-T08123-Ab-2; GM-Tg-equg-T08123-Ab-1/ GM-Tg-equg-T08123-Ab-2
Products NameAnti-LRRK2 monoclonal antibody
Formatmab
Target NameLRRK2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LRRK2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T08123-Ag-1Recombinant multi-species LRRK2/ AURA17/ DARDARIN protein


    Target information

    Target IDGM-T08123
    Target NameLRRK2
    Gene ID120892,66725,300160,697930,486608,101096157,535652,100052935
    Gene Symbol and Synonyms4921513O20Rik,9330188B09Rik,AURA17,cI-46,D630001M17Rik,DARDARIN,Gm927,LRRK2,PARK8,RIPK7,ROCO2
    Uniprot AccessionQ5S007
    Uniprot Entry NameLRRK2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseParkinson's disease
    Gene EnsemblENSG00000188906
    Target ClassificationKinase

    The target: LRRK2, gene name: LRRK2, also named as AURA17, DARDARIN, PARK8, RIPK7, ROCO2. This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.